- Home
- SBLK vs SLBT Comparison
SBLK vs SLBT Comparison
Compare SBLK & SLBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SBLK | SLBT |
|---|---|---|
| Founded | 2006 | N/A |
| Country | Greece | Taiwan |
| Employees | N/A | 20 |
| Industry | Marine Transportation | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.4B |
| IPO Year | 2007 | N/A |
Fundamental Metrics
Financial Performance| Metric | SBLK | SLBT |
|---|---|---|
| Price | $24.92 | $4.36 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $25.50 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 236.9K |
| Earning Date | 05-20-2026 | N/A |
| Dividend Yield | ★ 2.33% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $11.56 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $47.06 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.72 | $3.23 |
| 52 Week High | $28.50 | $6.25 |
Technical Indicators
Market Signals| Indicator | SBLK | SLBT |
|---|---|---|
| Relative Strength Index (RSI) | 39.88 | 47.45 |
| Support Level | $23.87 | $3.63 |
| Resistance Level | $27.29 | $4.91 |
| Average True Range (ATR) | 0.73 | 0.74 |
| MACD | -0.00 | -0.03 |
| Stochastic Oscillator | 19.24 | 32.12 |
Price Performance
Historical ComparisonAbout SBLK Star Bulk Carriers Corp.
Star Bulk Carriers Corp provides seaborne transportation solutions in the dry bulk sector. The company owns and operates dry bulk carrier vessels, which are used to transport bulk, such as iron ore, coal, grains, bauxite, fertilizers, and steel products. It owns a fleet of vessels that consists of Newcastlemax, Capesize, Post Panamax, Kamsarmax, Panamax, Ultramax, and Supramax. The firm generates the majority of its revenue from Time charters and Voyage charters.
About SLBT SL Science Holding Limited Ordinary Shares
SL Science Holding Ltd is a biomedical company specialized in developing cellular and gene therapies advancing regenerative medicine and cancer treatment. It utilizes immune stem cells to target cancer and bovine-derived milk exosomes to regenerate damaged tissues, thus potentially offering expansive medical applications for its products. With proprietary technologies such as Armed-T and Gamma Delta T cells, as well as exosome applications in skincare and cancer recovery. It operates in three segments namely Exosome products, CD-19 Armed-T products, and GDT cell therapy products. It derives revenue from Exosome products segment.